Author: BusinessWire

QUEBEC CITY, Quebec–(BUSINESS WIRE)–IMV Inc. (IMV) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Canadian bioresearch…

RFID technology improves accuracy and visibility of the medication supply chain, from the production line to the patient WASHINGTON–(BUSINESS WIRE)–Kit…

TIME-2b Study Did Not Meet the Primary Endpoint of 2-Step Reduction in DRSS Score Conference Call and Webcast Today, March…

Data demonstrates survival benefit with the Impella RP Recover Right protocol NEW ORLEANS, La.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/heartrecovery?src=hash" target="_blank"gt;#heartrecoverylt;/agt;–Abiomed (NASDAQ:ABMD), a leading…

-Proceeds to Advance IMR-687 for the Treatment of Sickle Cell Disease (SCD) and Thalassemia, and Expand Company Pipeline -New Investors:…

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…

DUBLIN–(BUSINESS WIRE)–The “Insulin Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s offering. The Insulin Intelligence Center is a global…

DUBLIN–(BUSINESS WIRE)–The “Insulin Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s offering. The Insulin Intelligence Center is a global…